Major histocompatibility complex-dependent susceptibility to Cryptococcus neoformans in mice

Infection and Immunity

Volumn 71, Issue 8, 2003, Pages 4815-4817

  McClelland, Erin E ^a,c   Granger, Donald L ^b   Potts, Wayne K ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGENIC STRAIN; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; EXPERIMENTAL INFECTION; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HOST RESISTANCE; INFECTION SENSITIVITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; COLONY COUNT, MICROBIAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; GENOTYPE; H-2 ANTIGENS; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; LIVER; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, CONGENIC; MICE, INBRED BALB C; MICE, INBRED C57BL; SPECIES SPECIFICITY;

EID: 0041743905     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.8.4815-4817.2003     Document Type: Article

References (26)

1. Abrahams, I. 1966. Further studies on acquired resistance to murine cryptococcosis: enhancing effect of Bordetella pertussis. J. Immunol. 96:525-529.
2. Aguirre, K. M., and G. W. Gibson. 2000. Differing requirement for inducible nitric oxide synthase activity in clearance of primary and secondary Cryptococcus neoformans infection. Med. Mycol. 38:343-353.
3. Aguirre, K. M., and L. L. Johnson. 1997. A role for B cells in resistance to Cryptococcus neoformans in mice. Infect. Immun. 65:525-530.
4. Ashman, R. B. 1987. Mouse candidiasis. II. Host responses are T-cell dependent and regulated by genes in the major histocompatibility complex. Immunogenetics 25:200-203.
5. Baum, H., and N. A. Staines. 1997. MHC-derived peptides and the CD4+ T-cell repertoire: implications for autoimmune disease. Cytokines Cell. Mol. Ther. 3:115-125.
6. Blake, J. A., J. E. Richardson, C. J. Bult, J. A. Kadin, and J. T. Eppig. 2002. The Mouse Genome Database (MGD): the model organism database for the laboratory mouse. Nucleic Acids Res. 30:113-115.
7. + T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice. Infect. Immun. 68:456-462.
8. Carroll, L. S., and W. K. Potts. 2001. Accumulated background variation among H2 mutant congenic strains: elimination through PCR-based genotyping of F2 segregants. J. Immunol. Methods 257:137-143.
9. Chen, C. Y., S. A. Cohen, M. B. Zaleski, and B. Albini. 1992. Genetic control of streptococcus-induced hepatic granulomatous lesions in mice. Immunogenetics 36:28-32.
10. Costantino, P. J., N. F. Gare, and J. R. Warmington. 1995. Humoral immune responses to systemic Candida albicans infection in inbred mouse strains. Immunol. Cell Biol. 73:125-133.
11. Decken, K., G. Köhler, K. Palmer-Lehmann, A. Wunderlin, F. Mattner, J. Magram, M. K. Gately, and G. Alber. 1998. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 66:4994-5000.
12. Dromer, F., P. Yeni, and J. Charreire. 1988. Genetic control of the humoral response to cryptococcal capsular polysaccharide in mice. Immunogenetics 28:417-424.
13. Gerlai, R. 1996. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci. 19:177-181.
14. Hormaeche, C. E., K. A. Harrington, and H. S. Joysey. 1985. Natural resistance to salmonellae in mice: control by genes within the major histocompatibility complex. J. Infect. Dis. 152:1050-1056.
15. Kappler, J. W., N. Roehm, and P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49:273-280.
16. + natural killer T cells by α-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect. Immun. 69:213-220.
17. Kawakami, K., Y. Koguchi, M. H. Qureshi, Y. Kinjo, S. Yara, A. Miyazato, M. Kurimoto, K. Takeda, S. Akira, and A. Saito. 2000. Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice. FEMS Microbiol. Lett. 186:121-126.
18. Lovchik, J. A., J. A. Wilder, G. B. Huffnagle, R. Riblet, C. R. Lyons, and M. F. Lipscomb. 1999. Ig heavy chain complex-linked genes influence the immune response in a murine cryptococcal infection. J. Immunol. 163:3907-3913.
19. McClelland, E. E., D. J. Penn, and W. K. Potts. 2003. Major histocompatibility complex heterozygote superiority during coinfection. Infect. Immun. 71:2079-2086.
20. Mody, C. H., C. J. L. Wood, R. M. Syme, and J. C. Spurrell. 1999. The cell wall and membrane of Cryptococcus neoformans possess a mitogen for human T lymphocytes. Infect. Immun. 67:936-941.
21. Perfect, J. R., S. D. Lang, and D. T. Durack. 1980. Chronic cryptococcal meningitis: a new experimental model in rabbits. Am. J. Pathol. 101:177-194.
22. Rhodes, J. C., L. S. Wicker, and W. J. Urba. 1980. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infect. Immun. 29:494-499.
23. Saha, B. K., and S. E. Cullen. 1986. Molecular mapping of murine I region recombinants: crossing over in the E beta gene. J. Immunol. 136:1112-1119.
24. Van Dam, M. G., R. A. Seaton, and A. J. Hamilton. 1998. Analysis of HLA association in susceptibility to infection with Cryptococcus neoformans vargattii in a Papua New Guinean population. Med. Mycol. 36:185-188.
25. Wolfer, D. P., and H. P. Lipp. 2000. Dissecting the behaviour of transgenic mice: is it the mutation, the genetic background, or the environment? Exp. Physiol. 85:627-634.
26. Yewdell, J. W., and J. R. Bennink. 1999. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17:51-88.